MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
14.04
+0.19 (1.37%)
At close: Oct 31, 2025, 4:00 PM EDT
14.32
+0.28 (1.99%)
After-hours: Oct 31, 2025, 4:41 PM EDT
MiNK Therapeutics Market Cap
MiNK Therapeutics has a market cap or net worth of $63.5 million as of October 31, 2025. Its market cap has increased by 141.51% in one year.
Market Cap
63.50M
Enterprise Value
67.33M
1-Year Change
141.51%
Ranking
Category
Stock Price
$14.04
Market Cap Chart
Since the IPO on October 15, 2021, MiNK Therapeutics's market cap has decreased from $386.36M to $63.50M, a decrease of -83.56%. That is a compound annual growth rate of -36.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 62.64M | 126.81% |
| Dec 31, 2024 | 27.62M | -25.23% |
| Dec 29, 2023 | 36.94M | -58.11% |
| Dec 30, 2022 | 88.18M | -40.99% |
| Dec 31, 2021 | 149.43M | -61.32% |
| Oct 15, 2021 | 386.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |